Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Add filters

Document Type
Year range
Journal of Investigative Dermatology ; 142(8):B19-B19, 2022.
Article in English | Web of Science | ID: covidwho-2010992
Journal of Investigative Dermatology ; 142(8):S40, 2022.
Article in English | EMBASE | ID: covidwho-1956215


Background: Hidradenitis suppurativa (HS) can severely impact quality of life. However, its specific impact on participation in social activities is not well studied. Objective: To assess HS’s interference with social activities in relation to disease severity. Methods: We recruited patients with a clinical diagnosis of HS (ICD-10 code L73.2) from clinic (n=30) and mail (n=123) to complete a survey. Respondents reported the extent to which HS interfered with social activities (none, a little, a lot). Disease severity was assessed using a validated self-assessment tool. Differences in disease severity were compared to degrees of interference with social activities using Chi-squared analysis. Results: A total of 67 completed responses were received and analyzed. Respondents were 22% Hurley Stage 1, 35% Hurley Stage 2, and 43% Hurley Stage 3 disease severity. Most reported HS interfered with their ability to go out (53%), engage in hobbies (57%), participate in sports or recreational activities (68%), go out socially or to a special event (65%), and go to parties (52%), with no significant differences by Hurley stage (p=0.31-0.68), though going out socially or to a special event (p=0.12) approached significance. Conclusion: Most patients in our cohort, regardless of disease severity, reported HS interfered with their social activities. HS is a physically and socially debilitating disease. Given social distancing policies during the COVID-19 pandemic, HS patients may be even more prone to isolation. Interventions to help HS patients with their social support structure may be helpful in improving their quality of life.

Journal of Investigative Dermatology ; 142(8, Supplement):B19, 2022.
Article in English | ScienceDirect | ID: covidwho-1936825